The Oligonucleotide Therapeutics Society (OTS) will hold its inaugural meeting at Rockefeller University on September 15-18. The meeting is sponsored by the New York Academy of Sciences in collaboration with OTS, with support from the National Cancer Institute and other companies. Presentations will cover

• methods of RNA targeting
• delivery of nucleic acid-based reagents and therapies
• immuno-modulation by nucleic acids
• identification and validation of targets and systems for preclinical studies
• novel oligonucleotides derivatives
• clinical studies and industry-driven therapeutic strategies

Click here for details of the meeting.